Last reviewed · How we verify

NCT03466762

Resilience and Quality of Life Among Cancer Survivors

Completed Last updated 9 January 2020
What this trial tests

trial testing Non applicable in Mental Health Wellness 1 in 500 participants. Completed in 30 June 2019.

Timeline
1 November 2018
Primary endpoint
30 June 2019
30 June 2019

Quick facts

Lead sponsorAga Khan University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment500
Start date1 November 2018
Primary completion30 June 2019
Estimated completion30 June 2019
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Aga Khan University

Who can join

18 and older, any sex, with Mental Health Wellness 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this study is to evaluate the impact of head \& neck cancer and brain tumors on lives of patients in Pakistan. To the best of the investigators knowledge this will be the first in-depth study to evaluate resilience and quality of life (QoL) among this group of patients. These patients encounter challenges as they battle to maintain optimistic outlook towards life. Resilience and QoL among them changes over time and may be modifiable towards increased well-being. Resilience and QoL are critical components during diagnosis, treatment, survivorship, and at the end of life. Hence, these are important traits for promoting positive psychological well-being. Through this study the investigators will be able to identify problems faced by such patients in our setting. the investigators will be able to plan appropriate interventions to improve a person's resiliency and quality of life, reduce depression and anxiety, and increase their satisfaction with life. This study is also aimed to inform healthcare providers and researchers regarding protective or risk characteristics for coping with cancer. Practices and resilience interventions may improve well-being and adherence to care guidelines. The objectives of our study are: Primary Objectives: * To determine resilience and quality of life scores after treatment separately for head \& neck cancer and Brain tumor patients in Pakistan. * To evaluate important factors associated with resilience and quality of life after treatment separately for head \& neck cancer and Brain tumor patients in Pakistan. Secondary Objective: • To examine the relationship between resilience and quality of life after treatment separately for head \& neck cancer and Brain tumor patients in Pakistan. It will be an analytical cross sectional study design. The study will be conducted at the Aga Khan University Hospital, Karachi. Study participants will be men and women greater than 18 years, with brain tumors or head \& neck cancer fulfilling the eligibility criteria. Approximately 250 patients will be recruiting with brain tumors and 250 with head \& neck cancer. Validated tools will be used to measure resilience and QoL.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Resilience and quality of life (QoL) of head and neck cancer and brain tumour survivors in Pakistan: an analytical cross-sectional study protocol.
    Zahid N, Khalid W, Ahmad K, Bhamani SS, et al · · 2019 · cited 13× · PMID 31542743 · DOI 10.1136/bmjopen-2019-029084

Verify or expand the search:

Other trials of Non applicable

Trials testing the same drug.

Other recruiting trials for Mental Health Wellness 1

Currently open trials in the same condition.

Other Aga Khan University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03466762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing